Abnormal P50 N95 Ratio Of Pattern Electroretinogram C4072977
An abnormal result on a specialized eye test measuring retinal response to patterns. May indicate issues with visual processing and typically warrants further eye examination.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(ophthalmologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Reduced contrast sensitivity
(ophthalmologic)Color vision deficiency
(ophthalmologic)Photophobia
(ophthalmologic)Generalized vision change
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Ophthalmologic Surveillance
Regular visual field testing, OCT imaging, and electroretinogram follow-up to monitor progression of retinal or optic nerve dysfunction indicated by abnormal P50/N95 ratios.
Neuroprotective Agents
Pharmacologic interventions to support retinal ganglion cell function and slow progression of optic nerve pathology.
Additional treatment options
Visual Protection and Environmental Modification
UV protection, reduced blue light exposure, adequate lighting conditions, and avoidance of factors that may exacerbate retinal stress.
lifestyleVisual Rehabilitation Therapy
Specialized exercises and training to maximize remaining visual function and develop compensatory visual strategies.
physical_therapyNutritional Support for Retinal Health
Dietary supplementation with nutrients supporting retinal function including antioxidants and omega-3 fatty acids as adjunctive therapy.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal P50 N95 Ratio Of Pattern Electroretinogram C4072977?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bach M, Poloschek CM. Electrophysiology and glaucoma: current concepts. Surv Ophthalmol. 2022.
Holder GE, Archer H, Dubis AM. Diagnostic utility of pattern ERG in retinal disease assessment. Clin Ophthalmol. 2020.
Parisi V, Scarale G, Balestrazzi E. Pattern electroretinogram in optic nerve diseases: a systematic review. Transl Vis Sci Technol. 2021.
International Society for Clinical Electrophysiology of Vision. ISCEV guidelines for clinical pattern electroretinography. Doc Ophthalmol. 2019.
Medication Comparisons
Compare medications used to treat Abnormal P50 N95 Ratio Of Pattern Electroretinogram C4072977. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy